<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>F. Tanser | Michael Schomaker</title>
    <link>https://MichaelSchomaker.github.io/authors/f.-tanser/</link>
      <atom:link href="https://MichaelSchomaker.github.io/authors/f.-tanser/index.xml" rel="self" type="application/rss+xml" />
    <description>F. Tanser</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Sat, 15 Jan 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://MichaelSchomaker.github.io/images/icon_hue888863bcf6448bbe1c2d7b1880687e8_12435_512x512_fill_lanczos_center_3.png</url>
      <title>F. Tanser</title>
      <link>https://MichaelSchomaker.github.io/authors/f.-tanser/</link>
    </image>
    
    <item>
      <title>Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15â€“19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2022-01-15_virologic_nonsuppression/</link>
      <pubDate>Sat, 15 Jan 2022 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2022-01-15_virologic_nonsuppression/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2021-03-01_virologic_response/</link>
      <pubDate>Thu, 21 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2021-03-01_virologic_response/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure</title>
      <link>https://MichaelSchomaker.github.io/publication/2020-01-01_the_impact_of_delaye/</link>
      <pubDate>Sat, 02 May 2020 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2020-01-01_the_impact_of_delaye/</guid>
      <description></description>
    </item>
    
    <item>
      <title>What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies</title>
      <link>https://MichaelSchomaker.github.io/publication/2019-01-01_what_should_we_do_wh/</link>
      <pubDate>Mon, 01 Apr 2019 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2019-01-01_what_should_we_do_wh/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Twelve-year mortality in adults initiating antiretroviral therapy in South Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2017-01-01_twelve-year_mortalit/</link>
      <pubDate>Mon, 25 Sep 2017 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2017-01-01_twelve-year_mortalit/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe</title>
      <link>https://MichaelSchomaker.github.io/publication/2017-01-01_optimal_timing_of_an/</link>
      <pubDate>Sat, 01 Apr 2017 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2017-01-01_optimal_timing_of_an/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1-5 Years:  A Causal Modelling Analysis from West and Southern Africa</title>
      <link>https://MichaelSchomaker.github.io/publication/2016-01-01_growth_and_mortality/</link>
      <pubDate>Tue, 01 Mar 2016 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2016-01-01_growth_and_mortality/</guid>
      <description></description>
    </item>
    
    <item>
      <title>CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2016-01-01_cd4_count_at_antiret/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2016-01-01_cd4_count_at_antiret/</guid>
      <description></description>
    </item>
    
    <item>
      <title>A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment</title>
      <link>https://MichaelSchomaker.github.io/publication/2015-01-01_a_comparison_of_deat/</link>
      <pubDate>Wed, 16 Dec 2015 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2015-01-01_a_comparison_of_deat/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study</title>
      <link>https://MichaelSchomaker.github.io/publication/2015-01-01_age_in_antiretrovira/</link>
      <pubDate>Thu, 01 Jan 2015 00:00:00 +0000</pubDate>
      <guid>https://MichaelSchomaker.github.io/publication/2015-01-01_age_in_antiretrovira/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
